Relationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients

Leila Mahmoodnia ¹, Maryam Sadoughi ¹, Ali Ahmadi ², Marzieh Kafeshani ³ *

Cited by CrossRef: 13

1- Salama D, Hammad F, Mohamed E, Ahmad I. Serum irisin level and its relation to diabetic nephropathy in patients with type 2 diabetes mellitus. 2021;5(2):347 [Crossref]

2- Mazloum Khorasani Z, Hosseini S, Safaei M, Mehrad Majd H, Sarabi M, Torshizian A, Nikpasand N, Saeedi N, AkbariRad M. The role of serum level of irisin in diabetic retinopathy. Int J Diabetes Dev Ctries. 2024;44(2):350 [Crossref]

3- Gao Q, Lu C, Wang X, Zhang J, Song Y, Xue Y. Molecular dynamics simulation and steered molecular dynamics simulation on irisin dimers. J Mol Model. 2018;24(4) [Crossref]

4- Ali E, Ali A, Al Ramly A, Muhamed M. Evaluation of serum irisin level in patients with chronic kidney disease. 2021;5(1):47 [Crossref]

5- El Haddad H, Sedrak H, Naguib M, Yousief E, Ibrahim D, Abdel Samie R, Hamdy A. Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications. Int J Diabetes Dev Ctries. 2019;39(4):641 [Crossref]

6- Abaj F, Mirzababaei A, Gholizadeh M, Aali Y, Jadidi P, Amiri Khosroshahi R, Clark C, Mirzaei K. Associations of dietary insulin load and dietary insulin index with diabetic nephropathy and reduced kidney function among women: a case–control study. J Health Popul Nutr. 2025;44(1) [Crossref]

7- Herouvi D, Vlachopapadopoulou E, Vakaki M, Gouriotis D, Marmarinos A, Kalpia C, Kossiva L, Tsolia M, Karavanaki K. Relation of serum irisin levels with adiposity, components of metabolic syndrome and carotid intima media thickness in prepubertal children with obesity: a cross-sectional study. Endocrine. 2024;87(3):1031 [Crossref]

8- Al-Rubaye A, Jasim W, Mohsin A. Myonectin, irisin, apelin-13 and Elabela hormones levels as biomarkers for type 2 diabetes mellitus : a systematic review. UkrBiochemJ. 2024;96(4):17 [Crossref]

9- He C, He W, Hou J, Chen K, Huang M, Yang M, Luo X, Li C. Bone and Muscle Crosstalk in Aging. Front Cell Dev Biol. 2020;8 [Crossref]

10- Deng X, Huang W, Peng J, Zhu T, Sun X, Zhou X, Yang H, Xiong J, He H, Xu Y, He Y. Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling. Inflammation. 2018;41(1):260 [Crossref]

11- Nayak S, Sahu P, Sahu R, Mahapatra S, Mohapatra D. Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study. Prosp Pharm Sc. 2024;22(3):210 [Crossref]

12- Aghasi M, Ghazi-Zahedi S, Koohdani F, Siassi F, Nasli-Esfahani E, Keshavarz A, Qorbani M, Khoshamal H, Salari-Moghaddam A, Sotoudeh G. The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial. BMC Complement Altern Med. 2018;18(1) [Crossref]

13- Ma J, Chen K. The role of Irisin in multiorgan protection. Mol Biol Rep. 2021;48(1):763 [Crossref]

14- Riwayadi D, Ambardini R, Sutapa P, Hardianto D, Ali S, Karakauki M, Aryanto S, Pratama K, Utami D, Kristianto A. Moderate Intensity Interval Training (MIIT) and High Intensity Interval Training (HIIT) exercise therapy against irisin levels in obesity. Fiz Pol. 2024;24(4):136 [Crossref]

15- Colaianni G, Errede M, Sanesi L, Notarnicola A, Celi M, Zerlotin R, Storlino G, Pignataro P, Oranger A, Pesce V, Tarantino U, Moretti B, Grano M. In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts. 2020;36(7):1420 [Crossref]